Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

被引：0
|
作者：
Pietanza, M. Catherine [1 ]
Travis, William D. [1 ]
Chan, Timothy A. [1 ]
Ginsberg, Michelle S. [1 ]
Kris, Andrei Holodny Mark G. [1 ]
Krug, Lee M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
PANCREAS | 2010年 / 39卷 / 02期
关键词：
D O I：
10.1097/01.mpa.0000363940.51906.5a
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [1] Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Pietanza, Maria Catherine
    Pereira, Leanne
    Dunne, Meghan
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Holodny, Andrei
    Kris, Mark G.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S819 - S820
  • [2] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (SCLC)
    Pietanza, M. C.
    Sima, C. S.
    Polley, M. R.
    Sumner, D. K.
    Travis, V.
    Heguy, A.
    Ginsberg, M. S.
    Holodny, A.
    Kris, M. G.
    Krug, L. M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S507 - S507
  • [3] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [4] A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer
    Han, Ji-Youn
    Kim, Hyae Young
    Lim, Kun Young
    Han, Jong Hee
    Lee, You Jin
    Kwak, Mi Hyang
    Kim, Hak Jin
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    LUNG CANCER, 2013, 79 (02) : 137 - 142
  • [5] Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer
    Yamamoto, N
    Tsurutani, J
    Yoshimura, N
    Asai, G
    Moriyama, A
    Nakagawa, K
    Kudoh, S
    Takada, M
    Minato, Y
    Fukuoka, M
    ANTICANCER RESEARCH, 2006, 26 (1B) : 777 - 781
  • [6] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
  • [7] Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer
    Tran, Sinhan
    Ready, Neal
    Krug, Lee M.
    Pietanza, Maria Catherine
    Jungbluth, Achim A.
    Pan, Linda S.
    Venhaus, Ralph Rudolph
    Hoffman, Eric W.
    Peters, Ann-Marie
    Dukelow, Karen
    Bomalaski, John S.
    Wu, Bor-Wen
    Old, Lloyd J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer
    Hirose, T
    Horichi, N
    Ohmori, T
    Ogura, K
    Hosaka, T
    Ando, K
    Ishida, H
    Noguchi, H
    Adachi, M
    LUNG CANCER, 2003, 40 (03) : 333 - 338
  • [9] Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine- DNA Methyltransferase as a Potential Biomarker
    Pietanza, M. Catherine
    Kadota, Kyuichi
    Huberman, Kety
    Sima, Camelia S.
    Fiore, John J.
    Sumner, Dyana K.
    Travis, William D.
    Heguy, Adriana
    Ginsberg, Michelle S.
    Holodny, Andrei I.
    Chan, Timothy A.
    Rizvi, Naiyer A.
    Azzoli, Christopher G.
    Riely, Gregory J.
    Kris, Mark G.
    Krug, Lee M.
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 1138 - 1145
  • [10] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345